24-Sep-2021 - Rheinische Friedrich-Wilhelms-Universität Bonn

Immune cells in the brain share the work

This cooperation is impaired in mutations that can cause Parkinson's disease

To break down toxic proteins more quickly, immune cells in the brain can join together to form networks when needed. This is shown by a joint study of the University of Bonn, the German Center for Neurodegenerative Diseases (DZNE) and the Institut François Jacob in France. However, in certain mutations that can cause Parkinson's disease, this cooperation is impaired.

The protein alpha-synuclein (abbreviated aSyn) performs important tasks in the nerve cells of the brain. But under certain circumstances, aSyn molecules can clump together and form insoluble aggregates. These damage the neurons; they are for instance typically found in the brains of people suffering from Parkinson's disease or Lewy body dementia.

The immune cells of the brain, the microglial cells, therefore try to break down and dispose of the aSyn aggregates. This process is not only time-consuming; it can also cause the microglial cells themselves to perish. "We have now identified a mechanism that addresses both problems," explains Prof. Dr. Michael Heneka. The researcher is director of the Department of Neurodegenerative Diseases and Geriatric Psychiatry at the University Hospital Bonn and conducts research there and at the DNZE on neurodegenerative diseases such as Parkinson's and Alzheimer's disease.

Division of labor prevents overload

The research suggests that microglial cells may spontaneously join together in order to better cope with threats. For this purpose, they form tube-like projections that dock onto neighboring microglial cells. These connections are then used to distribute the aSyn aggregates among the partners in the network. Without this division of labor, individual immune cells would have to shoulder a major part of the degradation work and would be overwhelmed.

Joining forces prevents that from happening. However, the connecting tubes also serve another purpose: Microglial cells can use them to give their neighbors a boost when they are in too much distress or indeed in mortal danger. "They then send mitochondria to neighboring cells that are busy breaking down the aggregates," explains Heneka's colleague Dr. Hannah Scheiblich. "Mitochondria function like little power plants; so they provide extra energy to the stressed cells."

In certain mutations, which are found more frequently in Parkinson's disease patients, both aSyn and mitochondrial transport are impaired. A similar situation applies to another disease in which the degradation of aSyn is impaired: Lewy body dementia. Researchers have isolated certain immune cells, the macrophages, from blood samples of affected individuals. These can be converted into microglia-like cells with the help of specific regulatory molecules. "These were still able to form networks in the lab. However, the transport of aSyn through the connecting tubes was severely impaired," says Heneka, who is also a member of the Cluster of Excellence Immunosensation2 and the transdisciplinary research area "Life & Health".

Findings may open up new therapeutic perspectives

The fact that microglial cells can join together was previously unknown. "We have opened the door to a field that will certainly engage researchers for many years to come," Heneka emphasizes. In the medium term, this may also open up new therapeutic perspectives for neurological disorders such as Parkinson's disease or dementia.

Facts, background information, dossiers

  • immune cells
  • brain
  • Parkinson's disease
  • mutations
  • microglia
  • alpha-Synuclein
  • dementia

More about Universität Bonn

  • News

    Study shows how bioactive substance inhibits important receptor

    The A2A receptor regulates how vigorously the innate immune system attacks diseased cells. Researchers at the University of Bonn have now been able to show for the first time how an important inhibitor binds to the receptor. In the future, the results will facilitate the targeted search for ... more

    New strategy for COVID-19 prophylaxis

    SARS-CoV-2 viruses can hide from recognition by the immune system. However, the antiviral immune receptor RIG-I can be stimulated, which improves protection against lethal SARS-CoV-2 infections. Researchers led by Prof. Gunther Hartmann from the Institute of Clinical Chemistry and Clinical ... more

    Protons are probably actually smaller than long thought

    A few years ago, a novel measurement technique showed that protons are probably smaller than had been assumed since the 1990s. This surprised the scientific community; some researchers even believed that the Standard Model of particle physics would have to be changed. Physicists at the Univ ... more

  • q&more articles

    A colorful variety of reactions

    The continuing trend towards sustainability, naturalness and healthy nutrition is making plant-based food ingredients with biofunctional and technofunctional properties increasingly important. Polyphenols, synthesized by plants as secondary metabolites, possess the molecular characteristics ... more

    How gold plasma can make hidden structures visible

    In recent years, microcomputed tomography (μCT) has become a standard method in many medical, scientific and industrial fields. This non-invasive technique enables three-dimensional imaging of a wide variety of structures. However, a new combination of methods now makes it possible to visua ... more

  • Authors

    Prof. Dr. Andreas Schieber

    Andreas Schieber, born in 1966, studied food chemistry at the University of Stuttgart and received his doctorate in 1996 from the University of Hohenheim. After his second state examination at the Chemical and Veterinary Investigation Office in Stuttgart, he returned to the university in 19 ... more

    Dr. Markus Lambertz

    Markus Lambertz, born in 1984, studied biology with a focus on zoology, paleontology and geology in Bonn, where he graduated with a diploma degree in 2010. After a research stay over several months in Ribeirão Preto (Brazil) he worked on his doctoral thesis in Bonn, receiving his doctorate ... more

    Prof. Dr. Jürgen Bajorath

    Jürgen Bajorath studied biochemistry and obtained diploma and Ph.D. degrees from the Free University Berlin (West). He is Professor and Chair of Life Science Informatics at the Bonn-Aachen International Center for Information Technology (B-IT) and the LIMES Institute of the University of Bo ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by: